Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGB PYGL PYGM	5.09e-08	3	75	3	GO:0008184
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGB PYGL PYGM	5.06e-07	5	75	3	GO:0004645
GeneOntologyMolecularFunction	tRNA (cytidine-3-)-methyltransferase activity	METTL2A METTL2B	8.31e-05	4	75	2	GO:0052735
GeneOntologyMolecularFunction	glycosyltransferase activity	GLT8D2 PYGB PYGL PYGM POGLUT2 DPY19L2P1 STT3B	1.04e-04	288	75	7	GO:0016757
GeneOntologyMolecularFunction	S-adenosylmethionine-dependent methyltransferase activity	PCIF1 NSD1 KMT2A METTL2A METTL2B	4.75e-04	172	75	5	GO:0008757
GeneOntologyMolecularFunction	retromer complex binding	IGF2R TBC1D5	6.14e-04	10	75	2	GO:1905394
GeneOntologyMolecularFunction	tRNA (cytidine) methyltransferase activity	METTL2A METTL2B	6.14e-04	10	75	2	GO:0016427
GeneOntologyMolecularFunction	hexosyltransferase activity	PYGB PYGL PYGM POGLUT2 STT3B	1.19e-03	211	75	5	GO:0016758
GeneOntologyMolecularFunction	pyridoxal phosphate binding	PYGB PYGL PYGM	1.22e-03	56	75	3	GO:0030170
GeneOntologyMolecularFunction	methyltransferase activity	PCIF1 NSD1 KMT2A METTL2A METTL2B	1.24e-03	213	75	5	GO:0008168
GeneOntologyMolecularFunction	vitamin B6 binding	PYGB PYGL PYGM	1.29e-03	57	75	3	GO:0070279
GeneOntologyMolecularFunction	transferase activity, transferring one-carbon groups	PCIF1 NSD1 KMT2A METTL2A METTL2B	1.55e-03	224	75	5	GO:0016741
GeneOntologyMolecularFunction	histone modifying activity	NSD1 KMT2A PRKDC EYA2 HDAC2	1.71e-03	229	75	5	GO:0140993
MousePheno	small pacinian corpuscles	ETV1 ETV4	1.87e-05	2	61	2	MP:0030998
MousePheno	decreased pacinian corpuscle number	ETV1 ETV4	1.87e-05	2	61	2	MP:0030996
MousePheno	abnormal pacinian corpuscle morphology	ETV1 ETV4	1.87e-05	2	61	2	MP:0000988
Domain	ETS_DOMAIN_1	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	1.15e-11	28	73	7	PS00345
Domain	ETS_DOMAIN_2	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	1.15e-11	28	73	7	PS00346
Domain	ETS	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	1.15e-11	28	73	7	SM00413
Domain	Ets_dom	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	1.15e-11	28	73	7	IPR000418
Domain	ETS_DOMAIN_3	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	1.15e-11	28	73	7	PS50061
Domain	Ets	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	1.15e-11	28	73	7	PF00178
Domain	PHOSPHORYLASE	PYGB PYGL PYGM	5.73e-08	3	73	3	PS00102
Domain	Phosphorylase	PYGB PYGL PYGM	5.73e-08	3	73	3	PF00343
Domain	Glycg_phsphrylas	PYGB PYGL PYGM	5.73e-08	3	73	3	IPR011833
Domain	Glyco_trans_35	PYGB PYGL PYGM	5.73e-08	3	73	3	IPR000811
Domain	ETS_PEA3_N	ETV1 ETV4 ETV5	5.73e-08	3	73	3	PF04621
Domain	ETS_PEA3_N	ETV1 ETV4 ETV5	5.73e-08	3	73	3	IPR006715
Domain	PNT	FLI1 ERG ETS2	9.24e-06	11	73	3	PS51433
Domain	Pointed_dom	FLI1 ERG ETS2	9.24e-06	11	73	3	IPR003118
Domain	SAM_PNT	FLI1 ERG ETS2	9.24e-06	11	73	3	PF02198
Domain	SAM_PNT	FLI1 ERG ETS2	9.24e-06	11	73	3	SM00251
Domain	-	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	2.27e-05	218	73	7	1.10.10.10
Domain	WHTH_DNA-bd_dom	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	4.43e-05	242	73	7	IPR011991
Domain	MeTrfase	METTL2A METTL2B	9.00e-05	4	73	2	IPR026113
Domain	Methyltransf_12	METTL2A METTL2B	2.24e-04	6	73	2	PF08242
Domain	Methyltransf_12	METTL2A METTL2B	2.24e-04	6	73	2	IPR013217
Domain	BTK	BMX TEC	5.33e-04	9	73	2	SM00107
Domain	Znf_Btk_motif	BMX TEC	5.33e-04	9	73	2	IPR001562
Domain	BTK	BMX TEC	5.33e-04	9	73	2	PF00779
Domain	ZF_BTK	BMX TEC	5.33e-04	9	73	2	PS51113
Domain	-	SEL1L IGF2R	1.14e-03	13	73	2	2.10.10.10
Domain	FN_type2_col-bd	SEL1L IGF2R	1.33e-03	14	73	2	IPR000562
Domain	FN2_2	SEL1L IGF2R	1.33e-03	14	73	2	PS51092
Domain	fn2	SEL1L IGF2R	1.33e-03	14	73	2	PF00040
Domain	FN2_1	SEL1L IGF2R	1.33e-03	14	73	2	PS00023
Domain	FN2	SEL1L IGF2R	1.33e-03	14	73	2	SM00059
Domain	Post-SET_dom	NSD1 KMT2A	1.75e-03	16	73	2	IPR003616
Domain	PostSET	NSD1 KMT2A	1.75e-03	16	73	2	SM00508
Domain	POST_SET	NSD1 KMT2A	1.75e-03	16	73	2	PS50868
Domain	Myosin-like_IQ_dom	ASPM MYO5C	2.47e-03	19	73	2	IPR027401
Domain	-	ASPM MYO5C	2.47e-03	19	73	2	4.10.270.10
Domain	EPHD	PHF6 KMT2A	3.31e-03	22	73	2	PS51805
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION	PYGB PYGL PYGM	4.64e-06	9	55	3	M47621
Pathway	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	PYGB PYGL PYGM	1.98e-05	14	55	3	M19193
Pathway	REACTOME_GLYCOGEN_METABOLISM	PYGB PYGL PYGM	1.22e-04	25	55	3	M27857
Pubmed	ETS-dependent regulation of a distal Gata4 cardiac enhancer.	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	6.62e-14	24	77	7	22056786
Pubmed	Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.	FLI1 ETS2 ETV1 ETV4 ETV5 FEV	2.86e-13	14	77	6	14635793
Pubmed	ETS-family genes in pancreatic development.	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	2.96e-13	29	77	7	17907201
Pubmed	Expression of dopamine pathway genes in the midbrain is independent of known ETS transcription factor activity.	ETS2 ETV1 ETV4 ETV5 FEV	2.13e-11	11	77	5	20610757
Pubmed	Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo.	FLI1 ERG ETV1 ETV4	2.22e-11	4	77	4	20517297
Pubmed	Articular cartilage endurance and resistance to osteoarthritic changes require transcription factor Erg.	FLI1 ERG ETS2 ETV1 ETV5 FEV	4.40e-11	29	77	6	26097038
Pubmed	An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.	ERG ETV1 ETV4 ETV5	1.11e-10	5	77	4	27783944
Pubmed	A novel zinc finger gene is fused to EWS in small round cell tumor.	FLI1 ERG ETV4 FEV	3.32e-10	6	77	4	10949935
Pubmed	Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains.	FLI1 ERG ETS2 ETV1	1.54e-09	8	77	4	9681824
Pubmed	ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.	ETV1 ETV4 ETV5	1.04e-08	3	77	3	22425584
Pubmed	PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro.	ETV1 ETV4 ETV5	1.04e-08	3	77	3	12871699
Pubmed	Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.	ETV1 ETV4 ETV5	1.04e-08	3	77	3	25203299
Pubmed	ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer.	ERG ETS2 ETV4	1.04e-08	3	77	3	22922762
Pubmed	Differential expression patterns of the PEA3 group transcription factors through murine embryonic development.	ETV1 ETV4 ETV5	1.04e-08	3	77	3	9285689
Pubmed	The role of Pea3 group transcription factors in esophageal squamous cell carcinoma.	ETV1 ETV4 ETV5	1.04e-08	3	77	3	21689625
Pubmed	Expression patterns of the Ets transcription factors from the PEA3 group during early stages of mouse development.	ETV1 ETV4 ETV5	1.04e-08	3	77	3	11578874
Pubmed	Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5.	ETV1 ETV4 ETV5	1.04e-08	3	77	3	28161714
Pubmed	β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1.	ETV1 ETV4 ETV5	4.17e-08	4	77	3	26627735
Pubmed	Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.	ERG ETV1 ETV4	4.17e-08	4	77	3	31584209
Pubmed	Pea3 transcription factor family members Etv4 and Etv5 mediate retrograde signaling and axonal growth of DRG sensory neurons in response to NGF.	ETV1 ETV4 ETV5	4.17e-08	4	77	3	24089499
Pubmed	The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity.	ETV1 ETV4 ETV5	4.17e-08	4	77	3	20062082
Pubmed	ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.	ETV1 ETV4 ETV5	4.17e-08	4	77	3	28408625
Pubmed	Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data.	ERG ETV1 ETV4	4.17e-08	4	77	3	18474293
Pubmed	Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.	ETS2 ETV1 ETV4 ETV5	6.64e-08	18	77	4	25117710
Pubmed	TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma.	FLI1 FLII ERG	1.04e-07	5	77	3	34329586
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GTPBP4 IGF2R USP11 NSD1 KMT2A PYGB PYGL PRKDC PRPF8 SNX9 HDAC2	2.04e-07	653	77	11	22586326
Pubmed	Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site.	ETV1 ETV4 ETV5	2.08e-07	6	77	3	15466854
Pubmed	Opposing functions of the ETS factor family define Shh spatial expression in limb buds and underlie polydactyly.	ETS2 ETV4 ETV5	2.08e-07	6	77	3	22340503
Pubmed	The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.	ETV1 ETV4 ETV5	3.63e-07	7	77	3	18977342
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	SEL1L GPD2 FLII EXOC5 USP11 TIMM50 PYGB PRPF8 SNX9 HDAC2	4.51e-07	560	77	10	35241646
Pubmed	COP1 is a tumour suppressor that causes degradation of ETS transcription factors.	ETV1 ETV4 ETV5	5.80e-07	8	77	3	21572435
Pubmed	Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.	ERG ETV1 PRKDC PRPF8	5.82e-07	30	77	4	21575865
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	GTPBP4 FLII TIMM50 PHF6 KMT2A PYGL C3 PRKDC PRPF8 STT3B	8.55e-07	601	77	10	33658012
Pubmed	Laminar patterning in the developing neocortex by temporally coordinated fibroblast growth factor signaling.	ETV1 ETV4 ETV5	1.24e-06	10	77	3	15470137
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	USP11 ZNF804B TIMM50 CSTA KMT2A GIGYF1 PRKDC MDM2 PRPF8 CDC23	1.48e-06	639	77	10	23443559
Pubmed	Emx2 patterns the neocortex by regulating FGF positional signaling.	ETV1 ETV4 ETV5	1.70e-06	11	77	3	12872126
Pubmed	Coordination of epithelial branching and salivary gland lumen formation by Wnt and FGF signals.	ETV1 ETV4 ETV5	1.70e-06	11	77	3	21806977
Pubmed	Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.	ETV1 ETV4 ETV5	1.70e-06	11	77	3	28827401
Pubmed	Human transcription factor protein interaction networks.	GTPBP4 FLI1 ERG USP11 TIMM50 ETV4 PHF6 ETV5 KMT2A FEV GIGYF1 MDM2 MYO5C HDAC2	2.73e-06	1429	77	14	35140242
Pubmed	Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2.	FLI1 ERG ETS2	2.94e-06	13	77	3	25802403
Pubmed	Role of Fgf8 signalling in the specification of rostral Cajal-Retzius cells.	ETV1 ETV4 ETV5	2.94e-06	13	77	3	20040495
Pubmed	Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development.	ETV1 ETV4 ETV5	3.73e-06	14	77	3	20215346
Pubmed	Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.	PYGB PYGL PYGM	4.66e-06	15	77	3	2575583
Pubmed	ERG and FLI1 protein expression in epithelioid sarcoma.	FLI1 ERG	4.84e-06	2	77	2	24072183
Pubmed	Fibroblast growth factors (FGFs) prime the limb specific Shh enhancer for chromatin changes that balance histone acetylation mediated by E26 transformation-specific (ETS) factors.	ETV4 HDAC2	4.84e-06	2	77	2	28949289
Pubmed	Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis.	FLI1 ERG	4.84e-06	2	77	2	28248553
Pubmed	The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis.	FLI1 ERG	4.84e-06	2	77	2	10704859
Pubmed	Downregulation of ERG and FLI1 expression in endothelial cells triggers endothelial-to-mesenchymal transition.	FLI1 ERG	4.84e-06	2	77	2	30500808
Pubmed	Transdifferentiation of erythroblasts to megakaryocytes using FLI1 and ERG transcription factors.	FLI1 ERG	4.84e-06	2	77	2	26063314
Pubmed	Ets transcription factors control epithelial maturation and transit and crypt-villus morphogenesis in the mammalian intestine.	ETS2 ETV5	4.84e-06	2	77	2	19264912
Pubmed	Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.	ETV1 ETV4	4.84e-06	2	77	2	25595908
Pubmed	Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins.	FLI1 ERG	4.84e-06	2	77	2	33275876
Pubmed	ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors.	FLI1 ERG	4.84e-06	2	77	2	26122367
Pubmed	Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.	ETV4 ETV5	4.84e-06	2	77	2	18827017
Pubmed	Pea3 Transcription Factors, Etv4 and Etv5, Are Required for Proper Hippocampal Dendrite Development and Plasticity.	ETV4 ETV5	4.84e-06	2	77	2	27909004
Pubmed	Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage.	FLI1 ERG	4.84e-06	2	77	2	19666492
Pubmed	YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion.	ERG ETV1	4.84e-06	2	77	2	21559405
Pubmed	Investigation of primary microcephaly in Bushehr province of Iran: novel STIL and ASPM mutations.	ASPM STIL	4.84e-06	2	77	2	22989186
Pubmed	Isoform-selective regulation of glycogen phosphorylase by energy deprivation and phosphorylation in astrocytes.	PYGB PYGM	4.84e-06	2	77	2	25130497
Pubmed	ETS-related transcription factors ETV4 and ETV5 are involved in proliferation and induction of differentiation-associated genes in embryonic stem (ES) cells.	ETV4 ETV5	4.84e-06	2	77	2	26224636
Pubmed	Ubiquitin ligase COP1 coordinates transcriptional programs that control cell type specification in the developing mouse brain.	ETV1 ETV4 ETV5	5.72e-06	16	77	3	30322923
Pubmed	Fli1 acts downstream of Etv2 to govern cell survival and vascular homeostasis via positive autoregulation.	FLI1 ERG ETS2	5.72e-06	16	77	3	24727028
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	SEL1L FLII CSTA C3 PRKDC PRPF8 TF	8.34e-06	327	77	7	31409639
Pubmed	Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription.	ETV1 ETV4 ETV5	9.86e-06	19	77	3	31442405
Pubmed	ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization.	ETV1 ETV4 ETV5	9.86e-06	19	77	3	22014525
Pubmed	Family with sequence similarity 60A (FAM60A) protein is a cell cycle-fluctuating regulator of the SIN3-HDAC1 histone deacetylase complex.	USP11 TIMM50 PRKDC HDAC2	1.28e-05	64	77	4	22865885
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	FLII TIMM50 CSTA PYGB PYGL C3 PRKDC TF HDAC2	1.32e-05	647	77	9	26618866
Pubmed	New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.	ETV1 ETV4 ETV5	1.35e-05	21	77	3	25035421
Pubmed	FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds.	ETV1 ETV4 ETV5	1.35e-05	21	77	3	19386269
Pubmed	Protein-tyrosine phosphatase D1, a potential regulator and effector for Tec family kinases.	BMX TEC	1.45e-05	3	77	2	11013262
Pubmed	Flightless-I mediates the repression of estrogen receptor α target gene expression by the glucocorticoid receptor in MCF-7 cells.	FLI1 FLII	1.45e-05	3	77	2	30369516
Pubmed	Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.	ERG ETV1	1.45e-05	3	77	2	17632455
Pubmed	Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.	ERG ETV1	1.45e-05	3	77	2	20104229
Pubmed	Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma.	ETV1 ETV4	1.45e-05	3	77	2	28859074
Pubmed	Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.	FLI1 ERG	1.45e-05	3	77	2	20308669
Pubmed	Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.	FLI1 ERG	1.45e-05	3	77	2	20308673
Pubmed	Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells.	NSD1 ETV5	1.45e-05	3	77	2	11509567
Pubmed	14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.	FLI1 ETV1	1.45e-05	3	77	2	23774214
Pubmed	TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions.	ERG ETV1	1.45e-05	3	77	2	17032499
Pubmed	ETS transcription factor ER81 is required for the Pacinian corpuscle development.	ETV1 ETV4	1.45e-05	3	77	2	16493690
Pubmed	Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells.	PRKDC MDM2	1.45e-05	3	77	2	25362358
Pubmed	Amplified segment in the 'Down syndrome critical region' on HSA21 shared between Down syndrome and euploid AML-M0 excludes RUNX1, ERG and ETS2.	ERG ETS2	1.45e-05	3	77	2	22221250
Pubmed	Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.	KMT2A PRKDC	1.45e-05	3	77	2	18538732
Pubmed	Etv5, an ETS transcription factor, is expressed in granulosa and cumulus cells and serves as a transcriptional regulator of the cyclooxygenase-2.	ETV4 ETV5	1.45e-05	3	77	2	18492810
Pubmed	Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16.	ERG ETS2	1.45e-05	3	77	2	14693372
Pubmed	Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance.	KMT2A PRKDC	1.45e-05	3	77	2	32763164
Pubmed	PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma.	ETV1 ETV4	1.45e-05	3	77	2	21673681
Pubmed	DALRD3 encodes a protein mutated in epileptic encephalopathy that targets arginine tRNAs for 3-methylcytosine modification.	METTL2A METTL2B	1.45e-05	3	77	2	32427860
Pubmed	FLI1 and ERG protein degradation is regulated via Cathepsin B lysosomal pathway in human dermal microvascular endothelial cells.	FLI1 ERG	1.45e-05	3	77	2	32979864
Pubmed	ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.	ERG ETS2	1.45e-05	3	77	2	19168790
Pubmed	A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.	FLI1 ERG	1.45e-05	3	77	2	20676125
Pubmed	DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.	PRKDC MDM2	1.45e-05	3	77	2	9363941
Pubmed	The Tec Kinase-Regulated Phosphoproteome Reveals a Mechanism for the Regulation of Inhibitory Signals in Murine Macrophages.	BMX TEC	1.45e-05	3	77	2	26026062
Pubmed	The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner.	BMX TNFRSF1A	1.45e-05	3	77	2	21471444
Pubmed	Endoglin expression in the endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a -8-kb enhancer.	FLI1 ERG	1.45e-05	3	77	2	16484587
Pubmed	FLII and MLL1 Cooperatively Regulate Aryl Hydrocarbon Receptor-Mediated Transcription in ARPE-19 Cells.	FLII KMT2A	1.45e-05	3	77	2	34698116
Pubmed	Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.	ERG ETV1	1.45e-05	3	77	2	16254181
Pubmed	Characterization of Tg(Etv4-GFP) and Etv5 RFP Reporter Lines in the Context of Fibroblast Growth Factor 10 Signaling During Mouse Embryonic Lung Development.	ETV4 ETV5	1.45e-05	3	77	2	30923534
Pubmed	Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.	ERG ETV1	1.45e-05	3	77	2	17390040
Pubmed	A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1 expression.	FLI1 ERG	1.45e-05	3	77	2	26261664
Interaction	KDM6A interactions	ERG ETV4 ETV5 KMT2A FEV EYA2 HDAC2	2.18e-06	162	74	7	int:KDM6A
Interaction	EP300 interactions	GTPBP4 FLII IGF2R ERG TIMM50 ETS2 ETV1 ETV4 PHF6 ETV5 C3 FEV PRKDC MDM2 PRPF8 SNX9 STT3B HDAC2	2.22e-06	1401	74	18	int:EP300
Interaction	ARID1B interactions	FLI1 ERG ETV4 PYGM FEV STIL EYA2	3.92e-06	177	74	7	int:ARID1B
Interaction	SIRT7 interactions	GTPBP4 IGF2R USP11 NSD1 KMT2A PYGB PYGL PRKDC MDM2 PRPF8 SNX9 HDAC2	1.57e-05	744	74	12	int:SIRT7
Interaction	ZNF609 interactions	EXOC5 ERG ETV4 FEV EYA2 HDAC2	1.61e-05	146	74	6	int:ZNF609
Interaction	KMT2D interactions	ERG ETV4 ETV5 KMT2A FEV EYA2	3.68e-05	169	74	6	int:KMT2D
Interaction	PPP1CA interactions	USP11 PCIF1 ASPM PYGB PYGL PYGM PRKDC TNFRSF1A MDM2 PRPF8 MYO5C	4.44e-05	696	74	11	int:PPP1CA
Interaction	MIDEAS interactions	ERG USP11 FEV ZC3H3 HDAC2	4.83e-05	108	74	5	int:MIDEAS
Interaction	MECOM interactions	GTPBP4 TIMM50 PHF6 PYGM FEV PRKDC SNX9 HDAC2	4.98e-05	358	74	8	int:MECOM
Interaction	CRYL1 interactions	FLII STIL CDC23 MYO5C	5.32e-05	56	74	4	int:CRYL1
Interaction	CRTC2 interactions	GIGYF1 MDM2 CDC23 HDAC2	7.46e-05	61	74	4	int:CRTC2
Interaction	C9orf78 interactions	SEL1L GPD2 FLII EXOC5 USP11 TIMM50 PYGB PRPF8 SNX9 HDAC2	8.62e-05	620	74	10	int:C9orf78
Interaction	DCD interactions	USP11 CSTA EYA2 MDM2 PRPF8 HDAC2	9.90e-05	202	74	6	int:DCD
Interaction	SPI1 interactions	ERG ETS2 ETV1 HDAC2	1.08e-04	67	74	4	int:SPI1
Interaction	PDX1 interactions	PCIF1 PRKDC HDAC2	1.16e-04	26	74	3	int:PDX1
Interaction	LOXL2 interactions	SEL1L FLII CSTA C3 PRKDC IDS PRPF8 TF	1.28e-04	410	74	8	int:LOXL2
Interaction	CIC interactions	FLII ERG USP11 TIMM50 FEV PRKDC EYA2 PRPF8 SNX9 HDAC2	1.69e-04	673	74	10	int:CIC
Interaction	ERG interactions	FLI1 ERG ETS2 ETV1 PRKDC PRPF8	1.70e-04	223	74	6	int:ERG
Interaction	NCOA2 interactions	FLII ERG ETV1 ETV4 FEV	1.71e-04	141	74	5	int:NCOA2
Interaction	NCOA3 interactions	FLII ERG ETS2 ETV1 ETV4 FEV	1.74e-04	224	74	6	int:NCOA3
GeneFamily	ETS transcription factor family	FLI1 ERG ETS2 ETV1 ETV4 ETV5 FEV	2.38e-12	28	57	7	534
GeneFamily	Glycogen phosphorylases	PYGB PYGL PYGM	2.97e-08	3	57	3	437
GeneFamily	PHD finger proteins	NSD1 PHF6 KMT2A	2.87e-03	90	57	3	88
GeneFamily	Methyltransferase like	METTL2A METTL2B	4.84e-03	33	57	2	963
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	NSD1 KMT2A	5.13e-03	34	57	2	487
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	FLI1 ERG ETV1 NSD1 ETV4 KMT2A FEV STIL TEC	4.05e-07	323	76	9	M9150
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	BMX ERG CD33 ASPM PYGL PYGM C3 STIL TF	1.13e-05	405	74	9	GSM538343_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	MAN1A2 ASPM ETV1 NSD1 REV3L IDS	5.95e-05	194	74	6	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2	ERG CD33 ASPM PYGM C3 STIL SNX9 TF	6.09e-05	388	74	8	GSM538352_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	SEL1L MAN1A2 ERG ETV1 ETV5 REV3L IDS ANKRD6 TF PCDH18 CDC23	6.83e-05	769	74	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05	KDELR3 GLT8D2 ETS2 ETV4 PYGM C3 TF	8.39e-05	300	74	7	PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	MAN1A2 ASPM ETV1 NSD1 REV3L CDC23 HDAC2	1.52e-04	330	74	7	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	ERG CD33 PYGL C3	1.68e-04	79	74	4	GSM538343_100
CoexpressionAtlas	DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#1_top-relative-expression-ranked_200	SEL1L MAN1A2 REV3L	1.70e-04	31	74	3	gudmap_developingKidney_e15.5_stage III -IV renal corpusc_200_k1
ToppCell	facs-Spleen-nan-3m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 ETS2 PYGL C3 TNFRSF1A	3.05e-07	156	77	6	f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655
ToppCell	facs-Spleen-nan-3m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 ETS2 PYGL C3 TNFRSF1A	3.05e-07	156	77	6	da4f35353a84d919e683554932f110e29568df33
ToppCell	facs-Spleen-nan-3m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 ETS2 PYGL C3 TNFRSF1A	3.05e-07	156	77	6	f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPD2 SLC8A1 NSD1 KMT2A REV3L ZC3H3	1.13e-06	195	77	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	VE-mono1-\|VE / Condition, Cell_class and T cell subcluster	SLC8A1 CD33 CSTA ETV5 PYGL C3	1.23e-06	198	77	6	2959d6e4992c36040ec9637f5a2daed02b35cf30
ToppCell	VE-mono1\|VE / Condition, Cell_class and T cell subcluster	SLC8A1 CD33 CSTA ETV5 PYGL C3	1.23e-06	198	77	6	c742871b8ec4720b1848991551c7c1f4000ebd85
ToppCell	facs-Spleen-nan-24m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3 TNFRSF1A	7.59e-06	156	77	5	034d4359359a44c205c6931f38a375271ac2752b
ToppCell	facs-Spleen-nan-24m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3 TNFRSF1A	7.59e-06	156	77	5	2a4dac4100c0339aad4905b8eaca6e8fe806718b
ToppCell	facs-Spleen-nan-24m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3 TNFRSF1A	7.59e-06	156	77	5	21267718d3a3dc19988663b6846aed8bb3eae836
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3 TNFRSF1A	1.09e-05	168	77	5	c0ff30e2c47005514131a0866cf10a1c228128fc
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3 TNFRSF1A	1.12e-05	169	77	5	1000eaf5158596b4898bedcc802b31db76b05a48
ToppCell	Control-T/NK_proliferative\|World / Disease group and Cell class	CD33 ASPM CSTA STIL NOSTRIN	1.12e-05	169	77	5	fca735cbb55fce4d32dc6632a39acea1d16b87ab
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3 TNFRSF1A	1.12e-05	169	77	5	83b854fa8fd9017df8f9207d9ced260eee98e8c1
ToppCell	facs-BAT-Fat-3m-Myeloid-granulocyte\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 ETS2 PYGL TNFRSF1A	1.15e-05	170	77	5	8fd0a55266066a51266ab616c38c883e2680bcf4
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 CD33 ETS2 CSTA PYGL	1.22e-05	172	77	5	968d18ab8c3cdeb7936a2aa721a7f41525763863
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IGF2R ASPM ETV4 NOSTRIN PCDH18	1.32e-05	175	77	5	3e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KDELR3 EYA2 TNFRSF1A TEC SLC16A12	1.40e-05	177	77	5	599cf7f5b774e197a1b43c98e4b9a8c1a618f38a
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ETV1 ETV5 C3 TF MYO5C	1.64e-05	183	77	5	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ETV1 ETV4 PYGB BFSP1 MYO5C	1.69e-05	184	77	5	d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	FLII IGF2R PYGB IDS SNX9	1.69e-05	184	77	5	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ETV1 ETV5 C3 TF MYO5C	1.73e-05	185	77	5	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ETS2 ANKRD6 MDM2 XKRX TEC	1.73e-05	185	77	5	dc59b8dc459a3c444c9634a0d438cbef54c40036
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ERG ETS2 MDM2 MYO5C HDAC2	1.87e-05	188	77	5	9858940c616e43441644c5a3bea8d832ee4daf79
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ETS2 ANKRD6 MDM2 XKRX TEC	1.87e-05	188	77	5	59b71462338a7efbacf46577cb07e9db3363afee
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM6 BMX ERG CSTA PYGL	1.92e-05	189	77	5	358ff514f1c8aa46067208ddf1b68396d789c130
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLI1 BMX ERG ZNF804B NOSTRIN	1.92e-05	189	77	5	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TRPM6 SLC8A1 BMX ETS2 PYGL	1.92e-05	189	77	5	235c24eeab5139f5821fccd5c879d8787682f4ef
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	FLI1 ERG ETS2 NOSTRIN MYO5C	1.97e-05	190	77	5	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM6 BMX ERG CSTA PYGL	2.02e-05	191	77	5	6c1283d51a845cff67ed5e500f7e944165297b53
ToppCell	B_cell_maturation-CD34+_pre-plamsa\|B_cell_maturation / Lineage and Cell class	ERG ETS2 TNFRSF1A MDM2 MYO5C	2.02e-05	191	77	5	4ee160a863d4fb9c4c9449633b9f337db8871992
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 CD33 ETS2 CSTA PYGL	2.23e-05	195	77	5	580ed65b4152483b642a7e7dbdf00d03588c46f6
ToppCell	hematopoetic_progenitors-CD34+_MPP\|World / Lineage and Cell class	ERG PYGL TNFRSF1A MYO5C HDAC2	2.23e-05	195	77	5	851064ca1ab727b4972ad4b72234ee130998a799
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPD2 SLC8A1 KMT2A REV3L ZC3H3	2.23e-05	195	77	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Classical_Monocyte\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC8A1 CD33 ETS2 CSTA PYGL	2.28e-05	196	77	5	76101d5ebe2a74c0a0a885ec31c3c1847bda8a7b
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 CD33 ETS2 CSTA PYGL	2.28e-05	196	77	5	f943519bff51c3094776fd45889dadf9062c8379
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLI1 BMX ERG NOSTRIN MYO5C	2.28e-05	196	77	5	629236f95c838a473b5964a49b7c1b7ad863ea12
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 CD33 ETS2 CSTA PYGL	2.34e-05	197	77	5	ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ETV1 ETV5 C3 TF MYO5C	2.34e-05	197	77	5	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 CD33 ETS2 CSTA PYGL	2.34e-05	197	77	5	b91016249b3585aa3536e96af18e4f1b1d2d5ce4
ToppCell	(7)_MNP\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SLC8A1 CD33 ETS2 CSTA PYGL	2.34e-05	197	77	5	6790346736946984cc80d67668523ba70ab0b380
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ETV1 ETV5 C3 TF MYO5C	2.40e-05	198	77	5	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	PBMC-Severe-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC8A1 CD33 ETS2 CSTA PYGL	2.40e-05	198	77	5	a8338da2477ccf8e3d924de8dbe1056b98111532
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	TRPM6 ERG ETS2 NOSTRIN MYO5C	2.40e-05	198	77	5	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	Monocytes\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SLC8A1 CD33 ETS2 CSTA C3	2.40e-05	198	77	5	8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61
ToppCell	PBMC-Severe-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLC8A1 CD33 ETS2 CSTA PYGL	2.40e-05	198	77	5	603846129560d5d6e6df27d6168f67f592e5e6e2
ToppCell	Sigmoid-Dendritic_cell-cycling_DCs\|Sigmoid / Region, Cell class and subclass	SLC8A1 ASPM ETS2 CSTA STIL	2.46e-05	199	77	5	bd6f8c0f79e9a94cc0f8c6105d38851463de821c
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC8A1 CD33 ETS2 CSTA C3	2.46e-05	199	77	5	de9c1c801eb34faf01760df07d5ff6bbd561e152
ToppCell	Non-neuronal-Postmitotic-Endothelial\|World / Primary Cells by Cluster	FLI1 ERG ETS2 NOSTRIN PCDH18	2.46e-05	199	77	5	b9763ac9857a60db6f1f104fe1e9ea2266cf931b
ToppCell	Non-neuronal-Postmitotic-Endothelial-Endothelial-24\|World / Primary Cells by Cluster	FLI1 ERG ETS2 NOSTRIN PCDH18	2.46e-05	199	77	5	0b4edf3e359749827ef978a77b5267ddde732d71
ToppCell	Sigmoid-(5)_Dendritic_cell-(50)_cDC2\|Sigmoid / shred on region, Cell_type, and subtype	SLC8A1 CD33 ETS2 CSTA TNFRSF1A	2.46e-05	199	77	5	402af84db90d8a49d67cf44c24766aefb00fd716
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC8A1 CD33 ETS2 CSTA TNFRSF1A	2.46e-05	199	77	5	c4fc638a8dad3a9b77634e8912a9326c8a2f11f5
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 CD33 ETS2 CSTA PYGL	2.46e-05	199	77	5	0f3ce61bbae69f7e333ed8dacf7257645624e163
ToppCell	Non-neuronal-Postmitotic-Endothelial-Endothelial\|World / Primary Cells by Cluster	FLI1 ERG ETS2 NOSTRIN PCDH18	2.46e-05	199	77	5	9e01eee126247a0696c71b019f855a8a41a0ede3
ToppCell	facs-Lung-18m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLI1 ERG ETS2 GIGYF1 TNFRSF1A	2.46e-05	199	77	5	c11e0044d3cc37f6bb26df033ad4448b419addfc
ToppCell	Sigmoid-(5)_Dendritic_cell-(52)_cycling_DCs\|Sigmoid / shred on region, Cell_type, and subtype	SLC8A1 ASPM ETS2 CSTA STIL	2.46e-05	199	77	5	8ee78a39729633bcbb3ab17e1dfaca33f38db569
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 CD33 ETS2 CSTA PYGL	2.46e-05	199	77	5	80ed217d28ba1c07facd0e103c25a02658dd848d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC8A1 CD33 ETS2 CSTA TNFRSF1A	2.46e-05	199	77	5	697a9a58c0cdb77222700d029873355d37f6ab28
ToppCell	Sigmoid-Dendritic_cell-cDC2\|Sigmoid / Region, Cell class and subclass	SLC8A1 CD33 ETS2 CSTA TNFRSF1A	2.46e-05	199	77	5	cd74db6db694b68f81dcf9d9342d125d00357ec1
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC8A1 CD33 ETS2 CSTA C3	2.46e-05	199	77	5	45e2f44a0ed39cb9ba061a03874c1fe746856c2d
ToppCell	10x5'-bone_marrow-Myeloid_Monocytic-Classical_monocytes\|bone_marrow / Manually curated celltypes from each tissue	SLC8A1 CD33 ETS2 CSTA PYGL	2.46e-05	199	77	5	2c747e9265594e12d46bd8c8de75c45e83144155
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FLI1 ERG ETS2 KMT2A NOSTRIN	2.52e-05	200	77	5	6f531a418ff25b59a543800cf4bce7b72404ce08
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLI1 ERG ETS2 KMT2A NOSTRIN	2.52e-05	200	77	5	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FLI1 ERG ETS2 REV3L NOSTRIN	2.52e-05	200	77	5	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Sigmoid-Dendritic_cell\|Sigmoid / Region, Cell class and subclass	SLC8A1 CD33 ETS2 CSTA TNFRSF1A	2.52e-05	200	77	5	994a49317b806d115c630cd90897a91fc85ff467
ToppCell	mild-HLA-DR-_S100A+_Monocyte\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLC8A1 CD33 ETS2 CSTA PYGL	2.52e-05	200	77	5	6dd89835a9f7bebb4849cff8eecb82caf6e1acbf
ToppCell	COVID-19-COVID-19_Severe-Myeloid\|COVID-19_Severe / Disease, condition lineage and cell class	SLC8A1 CD33 ETS2 CSTA PYGL	2.52e-05	200	77	5	1315bc0582b19c2fed91c740a1a7e9285c700df1
ToppCell	Sigmoid-(5)_Dendritic_cell\|Sigmoid / shred on region, Cell_type, and subtype	SLC8A1 CD33 ETS2 CSTA TNFRSF1A	2.52e-05	200	77	5	1130328863a4fcfa7dcd7261e9905943057777c5
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	ASPM ETV1 STIL NOSTRIN TMEM123	2.52e-05	200	77	5	0bba93f1271dac704dddcdea8cb0f84a7ac6f42a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	ASPM ETV1 STIL NOSTRIN TMEM123	2.52e-05	200	77	5	c9479452ab8c51139522383f745f02171ebbd7e2
ToppCell	(61)_LYVE1_Macrophage\|World / shred on Cell_type and subtype	SLC8A1 CD33 ETS2 CSTA PYGL	2.90e-05	206	77	5	711e961a9a03bfd2f0958bd14f25f7f207a2f2b5
ToppCell	PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMX CD33 CSTA PYGL	1.14e-04	144	77	4	1efa434e577d1f87e02df01667782f414d63bd60
ToppCell	PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMX CD33 CSTA PYGL	1.14e-04	144	77	4	c0c5f254a960ba5e5f1354599d54e77360e6c2ac
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 CD33 ETS2 TF	1.14e-04	144	77	4	a9305d2499189f23b942775285be9fb260ce4214
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMX CD33 CSTA PYGL	1.26e-04	148	77	4	74f1f9d1a53dc1a09cb6a504cbbdc7496c5b6879
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TRPM6 BMX ERG NOSTRIN	1.30e-04	149	77	4	d9c47f523c75ddcd6131e45d2ffc24b970932cae
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMX CD33 CSTA PYGL	1.30e-04	149	77	4	4de52569611e63a780cde9bd111d6d9c11a05a11
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMX CD33 CSTA PYGL	1.30e-04	149	77	4	c957ac23ad6343eacce7e6be4a6d3ac043af4f86
ToppCell	Myeloid-Myeloid-E_(Neutrophils)\|Myeloid / shred on cell class and cell subclass (v4)	BMX CD33 CSTA PYGL	1.33e-04	150	77	4	1bffb8d86b737ac43be902d9468041aef3542f1f
ToppCell	facs-Marrow-T-cells-24m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3	1.36e-04	151	77	4	ced4f7ee377a23a804ae6fde624e8b55b79f1fd8
ToppCell	facs-Marrow-T-cells-24m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3	1.36e-04	151	77	4	b52bb3b88e9a6473f571053537b8beb418678539
ToppCell	facs-Lung-24m-Hematologic-myeloid-neutrophil\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BMX CD33 ETS2 PYGL	1.58e-04	157	77	4	e96241db2b5ff52b230e3e33207e7bb968900cab
ToppCell	facs-Lung-24m-Hematologic-myeloid-neutrophil-neutrophil\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BMX CD33 ETS2 PYGL	1.58e-04	157	77	4	07a0f8d29a3111be670eae030a91474465eba734
ToppCell	droplet-Spleen-nan-24m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD33 PYGL C3 TNFRSF1A	1.62e-04	158	77	4	e1a8dba5a88bc3ce112829c5ecb112cbbee5b078
ToppCell	droplet-Spleen-nan-24m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD33 PYGL C3 TNFRSF1A	1.62e-04	158	77	4	72e4f8ae137a7dddee0dc6236532e0711065e6af
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLI1 BMX ERG NOSTRIN	1.70e-04	160	77	4	33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRPM6 BMX ETV1 PYGL	1.70e-04	160	77	4	bb1bb3673059768c0ea0160d29fff127f3a4ecb4
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM6 BMX ETV1 PYGL	1.70e-04	160	77	4	76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDELR3 C19orf67 ETV1 FEV	1.79e-04	162	77	4	ca1014e32996f777bff021830ce9a7cf4acf58d5
ToppCell	droplet-Fat-Gat\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL TNFRSF1A	1.87e-04	164	77	4	c7ad946829c655038b33748dddd7d68c15489034
ToppCell	droplet-Fat-Gat-18m\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL TNFRSF1A	1.87e-04	164	77	4	3aae702a23fbf1d36a6f18596c23e985581de815
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDELR3 PYGL FEV POGLUT2	1.87e-04	164	77	4	74a35ba77e93d864161beb6b133d654473981bb7
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX PYGL C3 TNFRSF1A	1.92e-04	165	77	4	b671c6a950e70f64776c2104baccb3dc2bb6a1ba
ToppCell	facs-BAT-Fat-3m-Myeloid-myeloid_cell\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL TNFRSF1A	1.92e-04	165	77	4	bfe330751d34813af7540765b490406078c40da7
ToppCell	facs-BAT-Fat-3m-Myeloid\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL TNFRSF1A	1.92e-04	165	77	4	8bdeacbb47948fabae2575689f811a9fad47f779
ToppCell	droplet-Spleen-nan-24m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3	1.92e-04	165	77	4	3cdb921f5b9facf04f81995d5641ac14ef3dbb6f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ETS2 NOSTRIN TF	1.96e-04	166	77	4	9d4b44eb56ad38c26aed73444edf389abca6bdf6
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3	2.05e-04	168	77	4	3611605114f6b668b44728d6563cd02389e106af
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3	2.10e-04	169	77	4	f38b52972a6c492ce2fd520a26bb3fc8db23bf85
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3	2.10e-04	169	77	4	5320da1d61806b53e0bd96bbdfdb8fd69246681b
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMX CD33 PYGL C3	2.10e-04	169	77	4	2341eddfedaad8cee779c37bb87f7def058588ca
Drug	3,5-dimethylphenyl isocyanate	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000521488
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000147839
Drug	NSC758405	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000151920
Drug	pyridoxal phosphoglucose	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000196007
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000191554
Drug	hydan	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000008360
Drug	EHMF	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000033931
Drug	pyridoxal 5'-methylenephosphonate	PYGB PYGL PYGM	3.43e-08	3	75	3	CID003082249
Drug	Plp 5'-mpa	PYGB PYGL PYGM	3.43e-08	3	75	3	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000191723
Drug	3'-FFdUrd	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000119518
Drug	AC1L8XK3	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000446801
Drug	riboflavin tetraacetate	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000094186
Drug	2,5-dimethyl-3-furanone	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000085730
Drug	3,5-dinitrophenol	PYGB PYGL PYGM	3.43e-08	3	75	3	CID000011459
Drug	galocitabine	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000065950
Drug	5-deoxyribose-1-phosphate	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000135786
Drug	ingliforib	PYGB PYGL PYGM	1.37e-07	4	75	3	CID006451325
Drug	uric acid riboside	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000164933
Drug	pseudo-dl-glucose	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000125259
Drug	pyridoxal diphosphate	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000125696
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000189134
Drug	AC1LAMW2	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000491364
Drug	FdUrd-C8	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000094262
Drug	Mem-CC	PYGB PYGL PYGM	1.37e-07	4	75	3	CID003081269
Drug	BCIp4A	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000192417
Drug	3'-chloromethotrexate	PYGB PYGL PYGM	1.37e-07	4	75	3	CID000097703
Drug	EF-T	FLI1 FLII ETV1 ETV4 FEV	2.96e-07	43	75	5	CID003054237
Drug	heptulose-2-P	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000124823
Drug	6-FPLP	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000146246
Drug	gluconohydroximo-1,5-lactone	PYGB PYGL PYGM	3.42e-07	5	75	3	CID009576855
Drug	DHPBU	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000125914
Drug	5'-isobutylthioinosine	PYGB PYGL PYGM	3.42e-07	5	75	3	CID003080910
Drug	indirubin-5-sulphonate	PYGB PYGL PYGM	3.42e-07	5	75	3	CID005288641
Drug	AC1LCUXJ	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000656425
Drug	6-amino-5-bromouracil	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000080578
Drug	etafenone	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000003275
Drug	ddEtUrd	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000125618
Drug	m-anisidine	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000010824
Drug	2-hydroxypropylphosphonate	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000441028
Drug	6-FDPL	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000129578
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGB PYGL PYGM	3.42e-07	5	75	3	CID003082179
Drug	GlcMan	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000152120
Drug	U66985	PYGB PYGL PYGM	3.42e-07	5	75	3	CID000127224
Drug	AC1O3M08	PYGB PYGL PYGM	3.42e-07	5	75	3	CID006331955
Drug	CV-araU	PYGB PYGL PYGM	6.82e-07	6	75	3	CID006441877
Drug	2-thiothymidine	PYGB PYGL PYGM	6.82e-07	6	75	3	CID003005944
Drug	Carbocyclic Bvdc	PYGB PYGL PYGM	6.82e-07	6	75	3	CID006438602
Drug	2,2-dimethyl-3-hydroxybutyric acid	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000152984
Drug	EdUMP	PYGB PYGL PYGM	6.82e-07	6	75	3	CID003085112
Drug	5'-deoxy-5'-chloroformycin	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000126430
Drug	5-n-propylthioadenosine	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000656428
Drug	AzddCyd	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000451374
Drug	5-Ffdru	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000065561
Drug	Carbocyclic Ivdu	PYGB PYGL PYGM	6.82e-07	6	75	3	CID006439191
Drug	DNPP	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000067056
Drug	5-chloro-indole-2-carboxylic acid	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000082693
Drug	NSC-97433	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000001803
Drug	AR-L57	PYGB PYGL PYGM	6.82e-07	6	75	3	CID000156890
Drug	BrVarafUTP	PYGB PYGL PYGM REV3L	1.10e-06	24	75	4	CID005273539
Drug	alpha-(fluoromethyl)dehydroornithine	PYGB PYGL PYGM	1.19e-06	7	75	3	CID006439607
Drug	6-fluoropyridoxal	PYGB PYGL PYGM	1.19e-06	7	75	3	CID003080803
Drug	AC1L3372	PYGB PYGL PYGM	1.19e-06	7	75	3	CID000108025
Drug	1 Gpt	PYGB PYGL PYGM	1.19e-06	7	75	3	CID000101247
Drug	formycins	PYGB PYGL PYGM	1.19e-06	7	75	3	CID000512867
Drug	5'-methylthioinosine	PYGB PYGL PYGM	1.19e-06	7	75	3	CID000161214
Drug	hydantocidin	PYGB PYGL PYGM	1.19e-06	7	75	3	CID000125429
Drug	2',3'-dideoxy-3'-fluorocytidine	PYGB PYGL PYGM	1.19e-06	7	75	3	CID000356019
Drug	heptenitol	PYGB PYGL PYGM	1.19e-06	7	75	3	CID000188267
Drug	Promonta	PYGB PYGL PYGM	1.19e-06	7	75	3	CID000108494
Drug	6-methylpurine	PYGB PYGL PYGM	1.90e-06	8	75	3	CID005287547
Drug	Etafenone [inn]	PYGB PYGL PYGM	1.90e-06	8	75	3	CID000066659
Drug	AC1NUVX5	PYGB PYGL PYGM	1.90e-06	8	75	3	CID005461894
Drug	amorphin	PYGB PYGL PYGM	1.90e-06	8	75	3	CID000122792
Drug	alpha-maltosyl fluoride	PYGB PYGL PYGM	2.84e-06	9	75	3	CID000194237
Drug	6-benzyl-2-thiouracil	PYGB PYGL PYGM	2.84e-06	9	75	3	CID000685814
Drug	5'-methylthiotubercidin	PYGB PYGL PYGM	2.84e-06	9	75	3	CID000188350
Drug	5-Iodoribose 1-phosphate	PYGB PYGL PYGM	2.84e-06	9	75	3	CID003035973
Drug	5'-iodo-5'-deoxyadenosine	PYGB PYGL PYGM	2.84e-06	9	75	3	CID000107502
Drug	A-skin	FLI1 ERG ETV1 FEV	3.64e-06	32	75	4	CID000208772
Drug	AC1LCV0V	NSD1 PYGB PYGL PYGM	3.64e-06	32	75	4	CID000656468
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A	GPD2 GTPBP4 EXOC5 ABCB9 CSTA ANKRD6 MDM2	3.81e-06	196	75	7	4728_DN
Drug	8-azidoadenosine 5'-monophosphate	PYGB PYGL PYGM	4.05e-06	10	75	3	CID000124726
Drug	6-methyluridine	PYGB PYGL PYGM	4.05e-06	10	75	3	CID000092887
Drug	UDP-pyridoxal	PYGB PYGL PYGM	4.05e-06	10	75	3	CID000126789
Drug	2,6-dihydroxypyridine	PYGB PYGL PYGM	4.05e-06	10	75	3	CID000069371
Drug	glucosyl fluoride	PYGB PYGL PYGM	5.56e-06	11	75	3	CID000150967
Drug	9 Da	PYGB PYGL PYGM	5.56e-06	11	75	3	CID005287565
Drug	Cid 11299980	PYGB PYGL PYGM	5.56e-06	11	75	3	CID009856533
Drug	AC1MO44M	PYGB PYGL PYGM TEC IDS	5.56e-06	77	75	5	CID003363163
Drug	AC1Q6SXM	GPD2 PYGB PYGL PYGM IDS	6.31e-06	79	75	5	CID000000717
Drug	L-BVAU	PYGB PYGL PYGM REV3L	7.36e-06	38	75	4	CID000667554
Drug	5'-deoxypyridoxal	PYGB PYGL PYGM	7.39e-06	12	75	3	CID000164889
Drug	BCX-34	PYGB PYGL PYGM	7.39e-06	12	75	3	CID000060817
Drug	Ap4U	PYGB PYGL PYGM	7.39e-06	12	75	3	CID000165888
Disease	Ewings sarcoma	FLI1 ERG ETV1 ETV4	2.39e-09	8	73	4	C0553580
Disease	bipolar disorder (implicated_via_orthology)	ETV1 ETV4 ETV5	5.05e-07	7	73	3	DOID:3312 (implicated_via_orthology)
Disease	obesity (implicated_via_orthology)	FLII TBC1D5 ETV1 ETV4 ETV5 C3	1.58e-05	215	73	6	DOID:9970 (implicated_via_orthology)
Disease	Extra-osseous Ewing's sarcoma	FLI1 ERG	3.61e-05	4	73	2	C0279980
Disease	tyrosine-protein kinase TEC measurement	TEC TEC	3.61e-05	4	73	2	EFO_0020830
Disease	Weaver syndrome	NSD1 KMT2A	6.01e-05	5	73	2	C0265210
Disease	Paratuberculosis	C3 TF	9.00e-05	6	73	2	C0030524
Disease	Adenoid Cystic Carcinoma	ASPM NSD1 PYGB PRKDC	1.13e-04	100	73	4	C0010606
Disease	Prostatic Neoplasms	IGF2R ERG ETV1 ETV4 ETV5 KMT2A PRKDC MDM2	1.41e-04	616	73	8	C0033578
Disease	Malignant neoplasm of prostate	IGF2R ERG ETV1 ETV4 ETV5 KMT2A PRKDC MDM2	1.41e-04	616	73	8	C0376358
Disease	microcephaly (is_implicated_in)	ASPM NSD1	1.67e-04	8	73	2	DOID:10907 (is_implicated_in)
Disease	Acute Myeloid Leukemia, M1	ERG CD33 NSD1 KMT2A	2.66e-04	125	73	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	ERG CD33 NSD1 KMT2A	2.66e-04	125	73	4	C1879321
Disease	TPE interval measurement	KDELR3 SLC8A1 PYGB	2.94e-04	52	73	3	EFO_0004644
Disease	colon carcinoma (is_marker_for)	IGF2R TNFRSF1A	4.63e-04	13	73	2	DOID:1520 (is_marker_for)
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	IGF2R C3	4.63e-04	13	73	2	DOID:332 (biomarker_via_orthology)
Disease	Autosomal recessive primary microcephaly	ASPM STIL	6.21e-04	15	73	2	cv:C3711387
Disease	lupus nephritis (is_marker_for)	C3 TNFRSF1A	8.02e-04	17	73	2	DOID:0080162 (is_marker_for)
Disease	Retinitis pigmentosa	TTC8 PDE6A PRPF8	8.30e-04	74	73	3	cv:C0035334
Disease	Myeloid Leukemia	KMT2A HDAC2	9.00e-04	18	73	2	C0023470
Disease	Leukemia, Monocytic, Chronic	KMT2A HDAC2	9.00e-04	18	73	2	C0023466
Disease	Leukemia, Myelocytic, Acute	ERG CD33 NSD1 KMT2A	9.06e-04	173	73	4	C0023467
Disease	glomerulonephritis (is_marker_for)	TNFRSF1A TF	1.00e-03	19	73	2	DOID:2921 (is_marker_for)
Disease	cystathionine measurement	TEC TEC	1.00e-03	19	73	2	EFO_0010474
Disease	IgA glomerulonephritis (is_marker_for)	C3 TNFRSF1A	1.11e-03	20	73	2	DOID:2986 (is_marker_for)
Disease	acute myeloid leukemia (is_implicated_in)	NSD1 PHF6 KMT2A	1.20e-03	84	73	3	DOID:9119 (is_implicated_in)
Disease	Primary microcephaly	ASPM STIL	1.35e-03	22	73	2	C0431350
Disease	Autosomal Recessive Primary Microcephaly	ASPM STIL	1.35e-03	22	73	2	C3711387
Disease	hemoglobin change measurement	KMT2A BFSP1	1.35e-03	22	73	2	EFO_0600027
Disease	cholelithiasis	KDELR3 NSD1 SNX9	1.37e-03	88	73	3	EFO_0004799
Disease	sensory peripheral neuropathy, remission	ETV1 KMT2A	1.48e-03	23	73	2	EFO_0009785, MONDO_0002321
Disease	adult respiratory distress syndrome (is_marker_for)	C3 TNFRSF1A	1.89e-03	26	73	2	DOID:11394 (is_marker_for)
Disease	Acute Confusional Senile Dementia	IGF2R CD33 TF	1.92e-03	99	73	3	C0546126
Disease	Alzheimer's Disease, Focal Onset	IGF2R CD33 TF	1.92e-03	99	73	3	C0750900
Disease	Alzheimer Disease, Early Onset	IGF2R CD33 TF	1.92e-03	99	73	3	C0750901
Disease	Presenile dementia	IGF2R CD33 TF	1.92e-03	99	73	3	C0011265
Disease	Alzheimer Disease, Late Onset	IGF2R CD33 TF	1.92e-03	99	73	3	C0494463
Disease	Familial Alzheimer Disease (FAD)	IGF2R CD33 TF	1.98e-03	100	73	3	C0276496
Disease	Alzheimer's Disease	IGF2R CD33 TF	2.03e-03	101	73	3	C0002395
Disease	Glycogen Storage Disease	PYGL PYGM	2.04e-03	27	73	2	C0017919
Disease	retinitis pigmentosa (implicated_via_orthology)	PDE6A PRPF8	2.04e-03	27	73	2	DOID:10584 (implicated_via_orthology)
Disease	Retinitis Pigmentosa	TTC8 PDE6A PRPF8	2.21e-03	104	73	3	C0035334

Protein segments in the cluster

Peptide	Gene	Start	Entry
FLYMYSRYLSGEKKK	CDC23	116	Q9UJX2
TNLSYYEYDKMKRGS	BMX	36	P51813
LSRALRYYYDKNIMS	FEV	101	Q99581
SRALRYYYDKNIMTK	ERG	366	P11308
KDYVRLMKYGDSLYR	GTPBP4	111	Q9BZE4
KIRYYTYLIMNKGRL	C3	486	P01024
RAYYQGKMQREKYLT	ASPM	2151	Q8IZT6
YQLYTLYRGKDGKVM	ANKRD6	391	Q9Y2G4
SRSLRYYYEKGIMQK	ETV4	396	P43268
YYYEKGIMQKVAGER	ETV4	401	P43268
SKMKVSNRRPYRQYY	NSD1	351	Q96L73
GNKYSRSYRYALQDM	PCDH18	851	Q9HCL0
FRTKMGLYYSYFKTI	DPY19L2P1	141	Q6NXN4
HYVTRMYRVYGKKNI	FLII	616	Q13045
RKFLYYEMGYKSRSE	GPD2	596	P43304
MPKYKLADYRYGREE	GIGYF1	31	O75420
GKEYKYLKNMFRTYQ	FLACC1	211	Q96Q35
YFFRMERGSTKYSYK	CD33	116	P20138
AYVTVYMIYGKFRKT	KDELR3	71	O43731
ALVRFMYSLSKGYRK	PDE6A	541	P16499
KMNYEKLSRGLRYYY	ETS2	411	P15036
RSLRYYYEKGIMQKV	ETV1	391	P50549
YYEKGIMQKVAGERY	ETV1	396	P50549
RDYGRYDMAQLRFKK	METTL2B	291	Q6P1Q9
NTYMGYLDYRKKAIK	GLT8D2	201	Q9H1C3
KLSRSLRYYYEKGIM	ETV5	421	P41161
LRYYYEKGIMQKVAG	ETV5	426	P41161
FLRKYRAMKQRYYSD	ETFRF1	71	Q6IPR1
RDYGRYDMAQLRFKK	METTL2A	291	Q96IZ6
SILYIGCKMYYSRRG	TMEM123	181	Q8N131
YLKSRSAMILQRYYD	EXOC5	356	O00471
VKTAFGRMLSYKYRS	C3orf49	86	Q96BT1
RYKGEMVKVSRNYFS	PCIF1	431	Q9H4Z3
MKETFKYFLRGYRYV	DCAKD	96	Q8WVC6
MYRRSYVFQTRKEQY	BFSP1	1	Q12934
SRALRYYYDKNIMTK	FLI1	336	Q01543
AYTASRFPRYLYKKM	C19orf67	221	A6NJJ6
TNYYIKVRAGDNKYM	CSTA	51	P01040
LSYLTGDLTYYKKVM	MAN1A2	346	O60476
YTAQRVKMKYGAWYL	FAM47A	686	Q5JRC9
MRKIYRGEELTYDYK	KMT2A	3931	Q03164
KIMGYSIRTIDYRYT	IDS	486	P22304
KRCRRKESYSMYIYK	H2BK1	26	A0A2R8Y619
YGLYRKMEIYRPHKA	HDAC2	46	Q92769
RFAKYYKMENGSEYR	P2RX3	281	P56373
NYYQKNMAGYSTRLK	NOSTRIN	186	Q8IVI9
AFRYRRVKEMYNTYK	EYA2	381	O00167
AKLSYYDGMIQLNYR	IGF2R	696	P11717
SKMYGLKSYIEYQLT	SNX9	261	Q9Y5X1
SMYYNGIGVKRDYKQ	SEL1L	491	Q9UBV2
SMLTYYEGRAEKKYR	TEC	36	P42680
KYFSRRKALAYGIAM	SLC16A12	166	Q6ZSM3
YFQRITLYLMGKKYS	IFNA16	146	P05015
YLGQYIMTKRLYDEK	MDM2	56	Q00987
MVSNIYGKYYKRLSK	ABCB9	341	Q9NP78
GQLTGMYRYKYKLMR	PRPF8	586	Q6P2Q9
YKYGYLTMDETRKLL	STIL	231	Q15468
AKYIENMSRGIYKLY	PHF6	311	Q8IWS0
QLRRTYKYFKDYRQM	TIMM50	111	Q3ZCQ8
REKRKEYCMYYNRFG	ZC3H3	666	Q8IXZ2
YYRLGMYREAEKQFK	TTC8	261	Q8TAM2
SYSIEKMYYLNKSKR	ZNF804B	856	A4D1E1
KMYLGYEYVTAIRNL	TF	331	P02787
KKYQYYSMPSSLLRS	TRPM6	1271	Q9BX84
KRIYYLSLEFYMGRT	PYGM	81	P11217
TKKRYVGYMYETLDQ	REV3L	2831	O60673
LLMQRYSKRVYIAYS	STT3B	281	Q8TCJ2
MAYTGKYLDKASYRV	TKTL2	136	Q9H0I9
KRIYYLSLEFYMGRT	PYGB	81	P11216
SFIVRYRMYASYKNL	POGLUT2	96	Q6UW63
YQETYLPYMIRSKLK	PRKDC	3036	P78527
YYKARGADLMNKSRT	TBC1D5	431	Q92609
ALYMVRIYRKNSETY	XKRX	51	Q6PP77
KRVYYLSLEFYMGRT	PYGL	81	P06737
GLMYRYQRWKSKLYS	TNFRSF1A	231	P19438
LYNVLMYRLSRYVTK	USP11	631	P51784
YKGIYMEEKLYRRAQ	ZNF285	166	Q96NJ3
YVYKRYRAGKQRGMI	SLC8A1	261	P32418
TYIEFYSRYGILMTK	MYO5C	691	Q9NQX4